Overview

Use of GM-CSF Supplemented IVF Medium in Patients With Recurrent Implantation Failure

Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
0
Participant gender:
Female
Summary
The purpose of this study is to determine whether in Assisted Reproductive Technologies the use of culture medium supplemented with GM-CSF, a growth factor working on stem cells, may improve the embryo implantation in patients experiencing recurrent implantation failure in IVF cycles.
Phase:
Phase 4
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Centre for Endocrinology and Reproductive Medicine, Italy
Criteria
Inclusion Criteria:

- woman age 40 years old or less,

- 3 or more consecutive previous failed IVF cycles with a total of at least 8 good
embryos replaced in uterus

Exclusion Criteria:

- chromosomal defects in the couple,

- metabolic diseases (diabetes, etc),

- other genetic diseases (thalassemia, cystic fibrosis, etc.)